PMID- 34882716 OWN - NLM STAT- MEDLINE DCOM- 20220110 LR - 20231108 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 16 IP - 12 DP - 2021 TI - Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing country. PG - e0260675 LID - 10.1371/journal.pone.0260675 [doi] LID - e0260675 AB - Type 2 diabetes mellitus (T2DM) is increasingly known as a risk factor of hepatocellular carcinoma (HCC). In this study, we determined the risk factors associated with HCC in T2DM patients. This was a matched case-control study conducted at two hepatobiliary referral centres in a developing country. Patients' sociodemographic, clinical, and biochemical characteristics between 1 January 2012 and 30 June 2018 were extracted from the electronic medical records and analysed using multivariate logistic regression analysis. A total of 212 case-control pairs were included. Significant risk factors included Chinese and Malay ethnicities that interacted with viral hepatitis (adjusted odds ratio [AOR] = 11.77, 95% confidence interval [CI]: 1.39-99.79) and (AOR = 37.94, 95% CI: 3.92-367.61) respectively, weight loss (AOR = 5.28, 95% CI: 2.29-12.19), abdominal pain/ discomfort (AOR = 6.73, 95% CI: 3.34-13.34), alcohol (AOR = 4.08, 95% CI: 1.81-9.22), fatty liver (AOR = 3.29, 95% CI: 1.40-7.76), low platelet (AOR = 4.03, 95% CI:1.90-8.55), raised alanine transaminase (AOR = 2.11, 95% CI: 1.16-3.86). and alkaline phosphatase (ALP) levels (AOR = 2.17, 95% CI: 1.17-4.00). Statins reduced the risk of HCC by 63% (AOR = 0.37, 95% CI: 0.21-0.65). The identification of these factors aids the risk stratification for HCC among T2DM patients for early detection and decision-making in patient management in the primary care setting. FAU - Azit, Noor Atika AU - Azit NA AUID- ORCID: 0000-0002-9645-2209 AD - Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia. FAU - Sahran, Shahnorbanun AU - Sahran S AD - Faculty of Information Science and Technology, National University of Malaysia, Bangi, Selangor, Malaysia. FAU - Voon Meng, Leow AU - Voon Meng L AD - Advanced Medical and Dental Institute (AMDI), USM, Kepala Batas, Penang, Malaysia. AD - Hepato-Pancreato-Biliary Unit, Department of Surgery, Hospital Sultanah Bahiyah, Ministry of Health Malaysia, Alor Setar, Kedah, Malaysia. FAU - Subramaniam, Manisekar AU - Subramaniam M AD - Hepato-Pancreato-Biliary Unit, Department of Surgery, Hospital Sultanah Bahiyah, Ministry of Health Malaysia, Alor Setar, Kedah, Malaysia. FAU - Mokhtar, Suryati AU - Mokhtar S AD - Hepato-Pancreato-Biliary Unit, Department of Surgery, Hospital Selayang, Ministry of Health Malaysia, Batu Caves, Selangor, Malaysia. FAU - Mohammed Nawi, Azmawati AU - Mohammed Nawi A AUID- ORCID: 0000-0002-0009-5244 AD - Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia. LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20211209 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Aged MH - Aged, 80 and over MH - Carcinoma, Hepatocellular/*epidemiology MH - Case-Control Studies MH - Clinical Decision-Making MH - Diabetes Mellitus, Type 2/*epidemiology MH - Female MH - Hepatitis, Viral, Human/*epidemiology MH - Humans MH - Liver Neoplasms/*epidemiology MH - Logistic Models MH - Malaysia/ethnology MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Retrospective Studies MH - Risk Factors PMC - PMC8659343 COIS- The authors declare no competing interest EDAT- 2021/12/10 06:00 MHDA- 2022/01/11 06:00 PMCR- 2021/12/09 CRDT- 2021/12/09 17:29 PHST- 2021/09/05 00:00 [received] PHST- 2021/11/13 00:00 [accepted] PHST- 2021/12/09 17:29 [entrez] PHST- 2021/12/10 06:00 [pubmed] PHST- 2022/01/11 06:00 [medline] PHST- 2021/12/09 00:00 [pmc-release] AID - PONE-D-21-28829 [pii] AID - 10.1371/journal.pone.0260675 [doi] PST - epublish SO - PLoS One. 2021 Dec 9;16(12):e0260675. doi: 10.1371/journal.pone.0260675. eCollection 2021.